Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Circulating microRNAs as biomarkers: a new frontier in diagnostics.

Steer CJ, Subramanian S.

Liver Transpl. 2012 Mar;18(3):265-9. doi: 10.1002/lt.23377. No abstract available.

2.

Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation.

Farid WR, Pan Q, van der Meer AJ, de Ruiter PE, Ramakrishnaiah V, de Jonge J, Kwekkeboom J, Janssen HL, Metselaar HJ, Tilanus HW, Kazemier G, van der Laan LJ.

Liver Transpl. 2012 Mar;18(3):290-7. doi: 10.1002/lt.22438.

3.

Plasma microRNA, a potential biomarker for acute rejection after liver transplantation.

Hu J, Wang Z, Tan CJ, Liao BY, Zhang X, Xu M, Dai Z, Qiu SJ, Huang XW, Sun J, Sun QM, He YF, Song K, Pan Q, Wu Y, Fan J, Zhou J.

Transplantation. 2013 Apr 27;95(8):991-9. doi: 10.1097/TP.0b013e31828618d8.

PMID:
23466638
4.

Circulating microRNAs as biomarkers for hepatocellular carcinoma.

Qu KZ, Zhang K, Li H, Afdhal NH, Albitar M.

J Clin Gastroenterol. 2011 Apr;45(4):355-60. doi: 10.1097/MCG.0b013e3181f18ac2.

PMID:
21278583
5.

Altered serum miRNA profiles during acute rejection after heart transplantation: potential for non-invasive allograft surveillance.

Sukma Dewi I, Torngren K, Gidlöf O, Kornhall B, Ohman J.

J Heart Lung Transplant. 2013 Apr;32(4):463-6. doi: 10.1016/j.healun.2012.12.007. Epub 2013 Feb 4. No abstract available.

PMID:
23384889
6.

MicroRNAs as biomarkers in solid organ transplantation.

Mas VR, Dumur CI, Scian MJ, Gehrau RC, Maluf DG.

Am J Transplant. 2013 Jan;13(1):11-9. doi: 10.1111/j.1600-6143.2012.04313.x. Epub 2012 Nov 8. Review.

7.

Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation.

Heidt S, San Segundo D, Shankar S, Mittal S, Muthusamy AS, Friend PJ, Fuggle SV, Wood KJ.

Transplantation. 2011 Jul 15;92(1):1-9. doi: 10.1097/TP.0b013e318218e978. Review.

PMID:
21494177
8.

Circulating microRNAs: emerging biomarkers of liver disease.

Arrese M, Eguchi A, Feldstein AE.

Semin Liver Dis. 2015 Feb;35(1):43-54. doi: 10.1055/s-0034-1397348. Epub 2015 Jan 29. Review.

PMID:
25632934
9.

Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?

Gehrau RC, Mas VR, Maluf DG.

Expert Rev Gastroenterol Hepatol. 2013 Feb;7(2):157-70. doi: 10.1586/egh.12.71. Review.

PMID:
23363264
10.

Impact of preoperative serum sodium concentration in living donor liver transplantation.

Fukuhara T, Ikegami T, Morita K, Umeda K, Ueda S, Nagata S, Sugimachi K, Gion T, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y.

J Gastroenterol Hepatol. 2010 May;25(5):978-84. doi: 10.1111/j.1440-1746.2009.06162.x.

PMID:
20546453
11.

Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre.

Muro M, Marin L, Miras M, Moya-Quiles R, Minguela A, Sánchez-Bueno F, Bermejo J, Robles R, Ramírez P, García-Alonso A, Parrilla P, Alvarez-López MR.

Transpl Immunol. 2005 Jun;14(2):91-7. Epub 2005 Apr 25.

PMID:
15935299
12.

Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease.

Gupta SK, Bang C, Thum T.

Circ Cardiovasc Genet. 2010 Oct;3(5):484-8. doi: 10.1161/CIRCGENETICS.110.958363. No abstract available.

13.

New aspects of RANTES in context of liver transplantation.

Schulz C, Schenk M, Zipfel A, Becker HD, Viebahn R.

Transplant Proc. 2001 Feb-Mar;33(1-2):414-5. No abstract available.

PMID:
11266889
14.

Participation of IL-18 in human cholestatic cirrhosis and acute rejection: analysis in living donor liver transplantation.

Yagi T, Iwagaki H, Urushihara N, Kobashi K, Nakao A, Matsukawa H, Sadamori H, Inagaki M, Tanaka N.

Transplant Proc. 2001 Feb-Mar;33(1-2):421-5. No abstract available.

PMID:
11266892
15.

Glutathione-S-transferase as a marker of acute graft rejection in orthotopic liver transplantation.

Diaz J, Carrascosa C, Acosta F, Marin C, Bueno FS, Cañizares F, Serrano E, Ramirez P, Parrilla P, Martinez P.

Transplant Proc. 1995 Aug;27(4):2305. No abstract available.

PMID:
7652818
16.

Consideration of preanalytical conditions to use circulating matrix metalloproteinases as diagnostic markers.

Jung K.

Transplantation. 2005 Mar 27;79(6):744. No abstract available.

PMID:
15785392
17.

Evolution of soluble forms of CD86, CD95 and CD95L molecules in liver transplant recipients.

Marín LA, Moya-Quiles MR, Miras M, Minguela A, Bermejo J, Ramírez P, García-Alonso AM, Parrilla P, Alvarez-López MR, Muro M.

Transpl Immunol. 2012 Mar;26(2-3):94-100. doi: 10.1016/j.trim.2011.12.001. Epub 2011 Dec 13.

PMID:
22182632
18.

Ceruloplasmin, a novel candidate as a diagnostic marker for liver function after liver transplantation.

Pan TL, Chen CL, Lin CL, Lai CY, Tseng HP, Chiang KC, Lin YC, Shu LW, Chen YS, Eng HL, Jawan B, Yokoyama H, Kitano S, Goto S.

Transplant Proc. 2000 Nov;32(7):2198. No abstract available.

PMID:
11120131
19.

Thyroid hormone in liver allograft rejection.

Antoniou EA, Rizos D, Achilleos O, Sarandakou A, Phocas I, D'Silva M, Papadimitriou J, McMaster P, Neuberger J.

Transplant Proc. 1997 Feb-Mar;29(1-2):503-4. No abstract available.

PMID:
9123104
20.

Impact of acute cellular rejection on coagulation and fibrinolysis biomarkers within the immediate post-operative period in pediatric liver transplantation.

Mimuro J, Mizuta K, Kawano Y, Hishikawa S, Hamano A, Kashiwakura Y, Ishiwata A, Ohmori T, Madoiwa S, Kawarasaki H, Sakata Y.

Pediatr Transplant. 2010 May;14(3):369-76. doi: 10.1111/j.1399-3046.2009.01248.x. Epub 2009 Sep 29.

PMID:
19793340

Supplemental Content

Support Center